Cryptotanshinone inhibits prostaglandin E2 production and COX-2 expression via suppression of TLR4/NF-κB signaling pathway in LPS-stimulated Caco-2 cells
- 1 March 2018
- journal article
- research article
- Published by Elsevier BV in Microbial Pathogenesis
- Vol. 116, 313-317
- https://doi.org/10.1016/j.micpath.2017.12.027
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Epidemiology and Natural History of Inflammatory Bowel DiseasesGastroenterology, 2011
- Importance of disrupted intestinal barrier in inflammatory bowel diseasesInflammatory Bowel Diseases, 2011
- Cryptotanshinone Inhibits Cancer Cell Proliferation by Suppressing Mammalian Target of Rapamycin–Mediated Cyclin D1 Expression and Rb PhosphorylationCancer Prevention Research, 2010
- Epithelial Tight Junctions in Intestinal InflammationAnnals of the New York Academy of Sciences, 2009
- Eicosanoids in inflammation and cancer: the role of COX-2Expert Review of Clinical Immunology, 2009
- Clinical manifestations of inflammatory bowel disease: East and West differencesJournal of Digestive Diseases, 2007
- BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2Gut, 2005
- LPS, TLR4 and infectious disease diversityNature Reviews Microbiology, 2005
- Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial LipopolysaccharideThe Journal of Immunology, 2001
- Comparative Tolerability of Treatments for Inflammatory Bowel DiseaseDrug Safety, 2000